Latin America & the Caribbean (LAC)
The work we do
Latin America and the Caribbean are building on their established vaccine manufacturing capabilities and regional procurement systems to strengthen health security and reduce reliance on imported vaccines. PAHO's Innovation and Regional Production Platform is supporting greater regional cooperation and production.
RVMC works with PAHO and other partners to identify opportunities to strengthen vaccine manufacturing and supply. We provide independent analysis to inform decisions about technology transfer, investment, and market access, helping ensure manufacturing plans reflect regional vaccine needs. We also connect partners across regions, sharing lessons from PAHO’s Revolving Fund to support similar efforts in Africa and ASEAN.
LAC Market Shaping Strategy
The 2026 Market-Shaping Strategy for Latin America and the Caribbean, developed by RVMC and CHAI, highlights significant progress in regional vaccine supply. The share of PAHO Revolving Fund procurement from regional manufacturers increased from less than 1% in 2020 to approximately 23% in 2025.
The priority now is to strengthen technology transfer agreements that enable manufacturers to supply markets across the region. Connecting manufacturing investments with regional vaccine priorities and purchasing commitments can help sustain production for routine immunization and future outbreaks.
RVM Insights
The RVM Insights Hub brings together evidence to help you understand what's changing, where challenges remain, and what comes next.
Explore our data and insights on vaccine manufacturing in LAC, covering manufacturing capabilities and regional supply, as well as the gaps and opportunities for progress.
2
The number of vaccine manufacturers in LAC producing five or more vaccines, with integrated manufacturing, annual capacity exceeding 70 million doses, and active exports.
25%
The share of regional vaccine demand in LAC, met by manufacturers within the region
9 of 13
The number of regional priority diseases for which at least one commercial vaccine is produced by a regional manufacturer
Related Resources
Other regions of focus
Africa
Africa aims to produce 60% of the vaccines it needs by 2040, yet regional manufacturers currently supply just 1% of demand. Discover how RVMC is supporting efforts to turn this ambition into sustainable vaccine supply.
ASEAN
ASEAN has a strong vaccine manufacturing base, but fragmented markets limit its potential. Explore how RVMC is supporting regional cooperation to strengthen vaccine security and self-reliance.
